Girij Pal Singh

USPTO Granted Patents = 32 (Patent Applications = 23)

EPO Patents = 10 (Patent Applications = 28)

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)

Location History:

Maharashtra, IN (2015 - 2020)
Pune, IN (2008 - 2022)

Company Filing History:

Les Laboratoires Servier

patents

Years Active: 2008-2022

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11248005 - Process for preparation of intermediates used for the synthesis of HIV integrase inhibitor (2022-02-15),

2. 10752618 - Process for the preparation of pure and stable crystalline Raltegravir potassium form 3 (2020-08-25),

3. 10752586 - Process for preparation of molindone (2020-08-25),

4. 10696636 - Process for the preparation of HIV integrase inhibitors (2020-06-30),

5. 10479787 - Process for preparation of tetrabenazine and deutetrabenazine (2019-11-19),

6. 10479776 - Process for the preparation of Efinaconazole (2019-11-19),

7. 10377712 - Process for preparation of apremilast and novel polymorphs thereof (2019-08-13),

8. 10259790 - Polymorphic forms of pitavastatin sodium (2019-04-16),

9. 10251850 - Process for preparation of cysteamine bitartrate (2019-04-09),

10. 10227317 - Process for the preparation of vortioxetine (2019-03-12),

11. 9981927 - Process for preparation of polymorphic form of Mirabegron (2018-05-29),

12. 9969691 - Polymorphic forms of pitavastatin sodium (2018-05-15),

13. 9932295 - Process for preparation of levothyroxine and salts thereof (2018-04-03),

14. 9163009 - Salts of raltegravir (2015-10-20),

15. 9127029 - Process for preparation of substantially pure fosamprenavir calcium and its intermediates (2015-09-08),

Title: Innovator Girij Pal Singh: Pioneering Patents in Pharmaceutical Chemistry

Introduction

Girij Pal Singh, based in Pune, India, is an accomplished inventor with an impressive portfolio of 32 patents. His contributions to pharmaceutical chemistry have made significant impacts, particularly in the development of innovative medicinal compounds aimed at addressing critical health issues, including HIV.

Latest Patents

Among his latest patents, Singh has introduced a process for the preparation of intermediates utilized in the synthesis of HIV integrase inhibitors. This patent outlines the method for preparing several essential compounds such as Bictegravir, Dolutegravir, and Cabotegravir, along with their pharmaceutically acceptable salts. Additionally, he has developed a process for the preparation of molindone. This patent specifies a detailed method involving several chemical reactions, ultimately yielding molindone and its potential salt forms.

Career Highlights

Girij Pal Singh has built a distinguished career in the pharmaceutical industry, having worked with notable companies including Lupin, Inc. and Les Laboratoires Servier. His expertise and innovative approaches have contributed to the advancements in drug development and synthesis, demonstrating his commitment to enhancing healthcare solutions.

Collaborations

Throughout his career, Singh has collaborated with talented individuals such as Himanshu Madhav Godbole and Sagar Purushottam Nehate. These partnerships have allowed for the exchange of ideas and creative solutions, further advancing their collective work in pharmaceutical innovations.

Conclusion

In conclusion, Girij Pal Singh’s extensive work and innovative patents highlight his role as a key contributor in the field of pharmaceutical chemistry. His continuous efforts to develop new processes and compounds pave the way for future advancements in medicine, playing a crucial part in the ongoing fight against HIV and other health challenges.

This text is generated by artificial intelligence and may not be accurate.